Federation des caisses Desjardins du Quebec
Position in SCLX — Scilex Holding Co
CIK 2022297
LEVIS, A8
Position in SCLX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$15
+$2 QoQ
Shares Held
2
-33.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#64
of 72 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SCLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Federation des caisses Desjardins du Quebec holds $784,151,867 across 18 Drug Manufacturers - General names. SCLX ranks #18 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
1,035,263 | $262,925,742 | |
| 2 | LLY |
ELI LILLY & Co
|
135,322 | $162,309,278 | |
| 3 | PFE |
Pfizer Inc
|
3,414,310 | $82,216,583 | |
| 4 | MRK |
Merck & Co., Inc.
|
514,231 | $66,078,682 | |
| 5 | ABBV |
AbbVie Inc.
|
212,267 | $53,414,866 | |
| 6 | AZN |
Astrazeneca PLC
|
209,951 | $39,810,907 | |
| 7 | SNY |
Sanofi
|
873,273 | $37,253,825 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
214,642 | $27,117,868 |
All Filings in SCLX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15 | 2 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $13 | 2 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $24 | 2 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $59 | 3 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $17 | 3 | Shares | Defined | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||